chenodeoxycholic acid has been researched along with Ataxia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bugalho, P; Cabral, P; Magriço, M | 1 |
Behzad-Noori, D; Brennan, K; Burgess, J; Longman, C | 1 |
Ikeda, S; Kato, T; Koyama, S; Maruyama, K; Sekijima, Y; Yoshida, T; Yoshinaga, T | 1 |
Chawla, BP; Mukherjee, AA; Puthran, RS; Rathi, SS | 1 |
4 other study(ies) available for chenodeoxycholic acid and Ataxia
Article | Year |
---|---|
Cerebrotendinous xanthomatosis: clinical and imaging clues of a rare treatable cause of ataxia.
Topics: Ataxia; Chenodeoxycholic Acid; Diagnostic Imaging; Humans; Magnetic Resonance Imaging; Xanthomatosis; Xanthomatosis, Cerebrotendinous | 2022 |
Double trouble: a case of an ataxic young man with coeliac disease and cerebrotendinous xanthomatosis.
Topics: Administration, Oral; Adult; Ataxia; Celiac Disease; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cognitive Dysfunction; Consanguinity; Delayed Diagnosis; Diet, Gluten-Free; DNA Mutational Analysis; Humans; Male; Medical History Taking; Mutation, Missense; Pedigree; Peripheral Nervous System Diseases; Treatment Outcome; Xanthomatosis, Cerebrotendinous | 2020 |
Clinical and radiological findings of a cerebrotendinous xanthomatosis patient with a novel p.A335V mutation in the CYP27A1 gene.
Topics: Achilles Tendon; Alanine; Ataxia; Brain; Cataract; Chenodeoxycholic Acid; Cholestanetriol 26-Monooxygenase; Cholestanol; Deglutition Disorders; Dysarthria; Dystonia; Early Diagnosis; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Spasticity; Muscle Weakness; Mutation; Pedigree; Radiography; Treatment Outcome; Valine; Xanthomatosis, Cerebrotendinous | 2014 |
Cerebrotendinous xanthomatosis: a treatable cause of metabolic ataxia.
Topics: Adult; Ataxia; Chenodeoxycholic Acid; Cholestanol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Xanthomatosis, Cerebrotendinous | 2007 |